Approval · Notice of Compliance 1164 · 2000
RENEDIL: Notice of Compliance 1164
Issued June 23, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1164
- Date
- June 23, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- FELODIPINE 2.5 MG per TAB
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB